1. Combination therapy with ropivacaine-loaded liposomes and nutrient deprivation for simultaneous cancer therapy and cancer pain relief
- Author
-
Wei Dai, Yunxia Cao, Xuesheng Liu, Erwei Gu, Qilian Tan, Fenfen Li, Zhaolian Wei, Lihai Chen, Guanghong Xu, Zhilai Yang, Jiqian Zhang, Qingqing Dai, Dan Cheng, Shasha Zhu, Youmei Zuo, and Lei Zhang
- Subjects
Male ,Vascular Endothelial Growth Factor A ,0301 basic medicine ,Oncology ,autophagy ,cancer pain ,medicine.medical_specialty ,Combination therapy ,Calorie restriction ,Uterine Cervical Neoplasms ,Medicine (miscellaneous) ,VEGF-A ,STAT3 ,HeLa ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Cell Line, Tumor ,Internal medicine ,medicine ,Animals ,Humans ,cancer ,Ropivacaine ,Anesthetics, Local ,Melanoma ,Pharmacology, Toxicology and Pharmaceutics (miscellaneous) ,Caloric Restriction ,biology ,business.industry ,Cancer ,biology.organism_classification ,medicine.disease ,Combined Modality Therapy ,Sciatic Nerve ,Mice, Inbred C57BL ,Disease Models, Animal ,030104 developmental biology ,030220 oncology & carcinogenesis ,Liposomes ,liposome ,Cancer cell ,Female ,Cancer pain ,business ,Research Paper ,medicine.drug - Abstract
Autophagy allows cancer cells to respond changes in nutrient status by degrading and recycling non-essential intracellular contents. Inhibition of autophagy combined with nutrient deprivation is an effective strategy to treat cancer. Pain is a primary determinant of poor quality of life in advanced cancer patients, but there is currently no satisfactory treatment. In addition, effective treatment of cancer does not efficiently relieve cancer pain, but may increase pain in many cases. Hence, few studies focus on simultaneous cancer therapy and pain relief, and made this situation even worse. Method: Ropivacaine was loaded into tumor-active targeted liposomes. The cytotoxicity of ropivacaine-based combination therapy in B16 and HeLa cells were tested. Moreover, a mice model of cancer pain which was induced by inoculation of melanoma near the sciatic nerve was constructed to assess the cancer suppression and pain relief effects of ropivacaine-based combination therapy. Results: Ropivacaine and ropivacaine-loaded liposomes (Rop-DPRL) were novelly found to damage autophagic degradation. Replicated administration of Rop-DPRL and calorie restriction (CR) could efficiently repress the development of tumor. In addition, administration of Rop-DPRL could relieve cancer pain with its own analgestic ability in a short duration, while repeated administration of Rop-DPRL and CR resulted in continuous alleviation of cancer pain through reduction of VEGF-A levels in advanced cancer mice. Further, dual inhibition of phosphorylation of STAT3 at Tyr705 and Ser727 by Rop-DPRL and CR contribute to the reduction of VEGF-A. Conclusion: Combination therapy with Rop-DPRL and nutrient deprivation simultaneously suppresses cancer growth and relieves cancer pain.
- Published
- 2020
- Full Text
- View/download PDF